RESEARCHER PROFILE

Winfried Brenner

← Back to Freie Universität Berlin

W

Freie Universität Berlin

Medical Imaging Techniques and ApplicationsRadiopharmaceutical Chemistry and ApplicationsNeuroendocrine Tumor Research AdvancesCardiac Imaging and DiagnosticsProstate Cancer Diagnosis and Treatment

Winfried Brenner works in Medical Imaging Techniques and Applications, Radiopharmaceutical Chemistry and Applications, Neuroendocrine Tumor Research Advances, Cardiac Imaging and Diagnostics, Prostate Cancer Diagnosis and Treatment. Recorded institutional associations include Humboldt-Universität zu Berlin, National Center for Tumor Diseases, Deutsches Konsortium für Translationale Krebsforschung.

492Publications
9,562Citations
50H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. German Multicenter Study Investigating 177 Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients

    2016 · 832 citations
  2. Assessment of the Tissue Distribution of Transplanted Human Endothelial Progenitor Cells by Radioactive Labeling

    2003 · 559 citations
  3. Monitoring Primary Systemic Therapy of Large and Locally Advanced Breast Cancer by Using Sequential Positron Emission Tomography Imaging With [18F]Fluorodeoxyglucose

    2008 · 212 citations
  4. 111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model.

    2004 · 193 citations
  5. PET imaging of osteosarcoma.

    2003 · 185 citations
  6. Pilot Trial on Determinants of Progenitor Cell Recruitment to the Infarcted Human Myocardium

    2008 · 183 citations
  7. Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial

    2020 · 182 citations
  8. S100B Protein Detection in Serum Is a Significant Prognostic Factor in Metastatic Melanoma

    1999 · 178 citations
  9. [18F]Fluorodeoxyglucose Positron Emission Tomography in Nonseminomatous Germ Cell Tumors After Chemotherapy: The German Multicenter Positron Emission Tomography Study Group

    2008 · 172 citations
  10. Immunohistochemical Validation of PSMA Expression Measured by 68Ga-PSMA PET/CT in Primary Prostate Cancer

    2017 · 161 citations
  11. FDG PET imaging for grading and prediction of outcome in chondrosarcoma patients

    2004 · 154 citations
  12. Myocardial CT Perfusion Imaging and SPECT for the Diagnosis of Coronary Artery Disease: A Head-to-Head Comparison from the CORE320 Multicenter Diagnostic Performance Study

    2014 · 132 citations
  13. Mandibular reconstruction with prefabricated vascularized bone grafts using recombinant human osteogenic protein-1: an experimental study in miniature pigs. Part II: Transplantation

    2001 · 127 citations
  14. Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer

    2008 · 125 citations
  15. Predictive value of serum S100B for monitoring patients with metastatic melanoma during chemotherapy and/or immunotherapy

    1999 · 122 citations
  16. Prognostic significance of serum S100B detection compared with routine blood parameters in advanced metastatic melanoma patients

    1999 · 110 citations
  17. [18F]-FDG–PET in clinical stage I/II non-seminomatous germ cell tumours: results of the German multicentre trial

    2008 · 107 citations
  18. Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours

    2006 · 103 citations
  19. Biodistribution of [68Ga]PSMA-HBED-CC in Patients with Prostate Cancer: Characterization of Uptake in Normal Organs and Tumour Lesions

    2016 · 97 citations
  20. Potential impact of 68Ga-DOTATOC PET/CT on stereotactic radiotherapy planning of meningiomas

    2009 · 96 citations
  21. The Role of Positron Emission Tomography in the Evaluation of Residual Masses After Chemotherapy for Advanced Stage Seminoma

    2008 · 95 citations
  22. Comparison of different quantitative approaches to 18F-fluoride PET scans.

    2004 · 94 citations
  23. Risk assessment in liposarcoma patients based on FDG PET imaging

    2006 · 92 citations
  24. Salivary gland protection by amifostine in high-dose radioiodine treatment: results of a double-blind placebo-controlled study.

    1998 · 89 citations
  25. Quantitative salivary gland scintigraphy.

    1999 · 89 citations

← Return to the university profile